Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.7 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |